Zoetis Inc. Restructuring Reserve, Noncurrent
Zoetis Inc. (ZTS) had Restructuring Reserve, Noncurrent of $2.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:RestructuringReserveNoncurrent · last filed 2026-08-06
- 2026-06-30: Restructuring Reserve, Noncurrent $2.00M.
- 2025-12-31: Restructuring Reserve, Noncurrent $2.00M.
- 2013-09-29: Restructuring Reserve, Noncurrent $9.00M.
- 2013-06-30: Restructuring Reserve, Noncurrent $9.00M.
| Period end | Restructuring Reserve, Noncurrent |
|---|---|
| 2026-06-30 | $2.00M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $2.00M 10-Q · filed 2026-08-06 |
| 2013-09-29 | $9.00M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $9.00M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $9.00M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $11.00M 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |